TGFα-PE38 enhances cytotoxic T-lymphocyte killing of breast cancer cells

The aim of the present study was to determine whether the combination of two modalities of immunotherapy, targeting two different tumor antigens, may be feasible and non-toxic, yet enhance the killing of a human breast cancer cell line. The first modality was tumor growth factor α-Pseudomonas exotox...

Descripción completa

Detalles Bibliográficos
Autores principales: WRIGHT, STEPHEN E., REWERS-FELKINS, KATHLEEN A., QUINLIN, IMELDA, CHOWDHURY, NAZRUL I., AHMED, JEWEL, ELDRIDGE, PAUL W., SRIVASTAVA, SANJAY K., PASTAN, IRA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049764/
https://www.ncbi.nlm.nih.gov/pubmed/24932299
http://dx.doi.org/10.3892/ol.2014.1969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049764/
https://www.ncbi.nlm.nih.gov/pubmed/24932299
http://dx.doi.org/10.3892/ol.2014.1969

Ejemplares similares